Clinical Trials Logo

Clinical Trial Summary

This study is a multi-center, randomized, double-blind, positive drug-controlled, non-inferiority Phase III clinical trial. The study will enroll approximately 316 infertile female subjects undergoing controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05994378
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact Zeli Li
Phone +86 0518-82342973
Email zeli.li.zl13@hengrui.com
Status Recruiting
Phase Phase 3
Start date August 29, 2023
Completion date June 30, 2025